Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;23(4):e13524.
doi: 10.1002/acm2.13524. Epub 2022 Feb 7.

Correlation of treatment time to target volume for GammaPod treatments: A simple second calculation

Leah Chen  1 , Stewart J Becker  1 , Sarah Anne McAvoy  1 , Elizabeth M Nichols  1 , Mariana Guerrero  1
Affiliations

Correlation of treatment time to target volume for GammaPod treatments: A simple second calculation

Leah Chen et al. J Appl Clin Med Phys. 2022 Apr.

Abstract

Purpose: The GammaPod is a novel device for stereotactic breast treatments that employs 25 rotating Co-60 sources while the patient is continuously translated in three axes to deliver a highly conformal dose to the target. There is no commercial software available for independent second calculations. The purpose of this study is to determine an efficient way to estimate GammaPod treatment times based on target volume and use it as a second calculation for patient-specific quality assurance.

Methods: Fifty-nine GammaPod (Xcision Medical Systems, LLC.) breast cancer patient treatments were used as the fitting dataset for this study. Similar to the Curie-seconds concept in brachytherapy, we considered dose-rate × time/(prescribed dose) as a function of target volumes. Using a MATLAB (Mathworks, Natick, MA, USA) script, we generated linear (with 95% confidence interval (CI)) and quadratic fits and tested the resulting equations on an additional set of 30 patients.

Results: We found a strong correlation between the dose-rate × time/(prescribed dose) and patients' target volumes for both the linear and quadratic models. The linear fit was selected for use and using the polyval function in MATLAB, a 95% CI graph was created to depict the accuracy of the prediction for treatment times. Testing the model on 30 additional patients with target volumes ranging from 20 to 188 cc yielded treatment times from 10 to 25 min that in all cases were within the predicted CI. The average absolute difference between the predicted and actual treatment times was 1.0 min (range 0-3.3 min). The average percent difference was 5.8% (range 0%-18.4%).

Conclusion: This work has resulted in a viable independent calculation for GammaPod treatment times. This method has been implemented as a spreadsheet that is ready for clinical use to predict and verify the accuracy of breast cancer treatment times.

Keywords: GammaPod; second calculation.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Linear fit of T NORM (dose‐rate × time/(prescribed dose)) versus PTV target volume (cc) calculation with the 95% confidence interval (CI). Both fitting and testing data are plotted
See this image and copyright information in PMC

References

    1. Becker S, Sabouri P, Niu Y, et al. Commissioning and acceptance guide for the GammaPod. Phys Med Biol. 2019;64(20):205021. - PubMed
    1. Mutaf YD, Zhang J, Yu CX, et al. Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer: the GammaPod. Med Phys. 2013;40(4):041722. - PubMed
    1. Yu CX, Shao X, Zhang J, et al. GammaPod—a new device dedicated for stereotactic radiotherapy of breast cancer. Med Phys. 2013;40(5):051703. - PMC - PubMed
    1. Becker SJ, Culberson WS, Poirier Y, et al. Dosimetry evaluation of the GammaPod stereotactic radiosurgery device based on established AAPM and IAEA protocols. Med Phys. 2020;47(8):3614‐3620. - PubMed
    1. Nichols EM, McAvoy S, Becker S. Nichols EM, McAvoy S, Becker S. Abstract P4‐12‐17: initial clinical experience and acute toxicity report of patients treated with accelerated partial breast irradiation (APBI) using the GammaPodTM . Cancer Res. 2020;80(4).